O. Durrani, N. Tehrani, J. Marr, P. Moradi, P. Stavrou et al., Degree, duration, and causes of visual loss in uveitis, British Journal of Ophthalmology, vol.88, issue.9, pp.1159-62, 2004.
DOI : 10.1136/bjo.2003.037226

O. Durrani, C. Meads, and P. Murray, Uveitis: a potentially blinding disease. Ophthalmologica, Review, vol.218, issue.4, pp.223-259, 2004.
DOI : 10.1159/000078612

J. Rosenbaum, Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease, Clinical Rheumatology, vol.45, issue.7, pp.999-1002
DOI : 10.1007/s10067-015-2960-8

C. Stolwijk, A. Van-tubergen, J. Castillo-ortiz, and A. Boonen, Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis

B. Bodaghi, B. Wechsler, L. Du-boutin, N. Cassoux, P. Lehoang et al., Chronic Severe Uveitis, Medicine, vol.80, issue.4, 2003.
DOI : 10.1097/00005792-200107000-00005

R. Grajewski, A. Caramoy, K. Frank, A. Rubbert-roth, G. Fätkenheuer et al., Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients, Ocular Immunology and Inflammation, vol.52, issue.4, pp.1-7, 2015.
DOI : 10.1007/s00417-009-1239-7

E. Jakob, M. Reuland, F. Mackensen, N. Harsch, M. Fleckenstein et al., Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients, J Rheumatol, vol.36, issue.1, pp.127-163, 2009.

A. Nguyen, P. Sève, L. Scanff, J. Gambrelle, J. Fleury et al., Aspects cliniques et ??tiologiques des uv??ites??: ??tude r??trospective de 121??patients adress??s ?? un centre tertiaire d???ophtalmologie, La Revue de M??decine Interne, vol.32, issue.1, pp.9-16, 2011.
DOI : 10.1016/j.revmed.2010.07.020

E. Bloch-michel and R. Nussenblatt, International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory Disease, American Journal of Ophthalmology, vol.103, issue.2, pp.234-239, 1987.
DOI : 10.1016/S0002-9394(14)74235-7

S. Reeves, F. Sloan, P. Lee, and G. Jaffe, Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort, Ophthalmology. Feb, vol.113, issue.2, p.307, 2006.

A. Bajwa, D. Osmanzada, S. Osmanzada, I. Khan, J. Patrie et al., Epidemiology of uveitis in the mid-Atlantic United States, Clinical Ophthalmology, vol.9, pp.889-901
DOI : 10.2147/OPTH.S80972

N. Acharya, V. Tham, E. Esterberg, D. Borkar, J. Parker et al., Incidence and Prevalence of Uveitis, JAMA Ophthalmology, vol.131, issue.11, pp.1405-1417, 2013.
DOI : 10.1001/jamaophthalmol.2013.4237

D. Gritz and I. Wong, Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study, Ophthalmology, vol.111, issue.3, pp.491-500, 2004.
DOI : 10.1016/j.ophtha.2003.06.014

C. Mccannel, G. Holland, C. Helm, P. Cornell, J. Winston et al., Causes of Uveitis in the General Practice of Ophthalmology, American Journal of Ophthalmology, vol.121, issue.1, pp.35-46, 1996.
DOI : 10.1016/S0002-9394(14)70532-X

S. Lin, S. Lee, S. Kim, S. Hong, Y. You et al., Prevalence of Toxoplasma gondii and Toxocara canis among patients with uveitis, Ocul Immunol Inflamm, 2014.

P. Zarco, C. González, A. Rodríguez-de-la-serna, E. Peiró, I. Mateo et al., Extra-articular Disease in Patients With Spondyloarthritis. Baseline Characteristics of the Spondyloarthritis Cohort of the AQUILES Study, Reumatolog??a Cl??nica (English Edition), vol.11, issue.2, pp.83-92, 2015.
DOI : 10.1016/j.reumae.2014.11.001

J. Chang, P. Mccluskey, and D. Wakefield, Acute Anterior Uveitis and HLA-B27, Survey of Ophthalmology, vol.50, issue.4, pp.364-88, 2005.
DOI : 10.1016/j.survophthal.2005.04.003

D. Monnet, M. Breban, C. Hudry, M. Dougados, and A. Brézin, Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis*1A study of 175 cases, Ophthalmology, vol.111, issue.4, pp.802-811, 2004.
DOI : 10.1016/j.ophtha.2003.07.011

L. Cabane, S. Baillif, G. Asrarguis, P. Gastaud, V. Queyrel et al., Uv??ite et spondylo-arthrite??: savoir ??voquer une tuberculose??!, Journal Fran??ais d'Ophtalmologie, vol.39, issue.4, pp.83-87
DOI : 10.1016/j.jfo.2015.01.029

A. Gupta, A. Sharma, R. Bansal, and K. Sharma, Classification of Intraocular Tuberculosis, Ocular Immunology and Inflammation, vol.26, issue.1, pp.7-13
DOI : 10.1136/bjo.2010.182659

V. Gupta, S. Shoughy, S. Mahajan, M. Khairallah, J. Rosenbaum et al., Clinics of Ocular Tuberculosis, Ocular Immunology and Inflammation, vol.57, issue.1, pp.14-24, 2015.
DOI : 10.1080/09273940490518702

D. Ponce-de-leon, E. Acevedo-vasquez, S. Alvizuri, C. Gutierrez, M. Cucho et al., Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population, J Rheumatol, vol.35, issue.5, pp.776-81, 2008.

M. Ang, H. Htoon, and S. Chee, Diagnosis of Tuberculous Uveitis: Clinical Application of an Interferon-gamma Release Assay, Ophthalmology, vol.116, issue.7, pp.1391-1397, 2009.
DOI : 10.1016/j.ophtha.2009.02.005

M. Van-der-veen, A. Van-der-heide, A. Kruize, and J. Bijlsma, Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate., Annals of the Rheumatic Diseases, vol.53, issue.4, 1994.
DOI : 10.1136/ard.53.4.224

M. Djebbar, infection risk when receiving anti TNF treatment: crucial and major concern or not so bad reality ?, Rev Mar Rhum, vol.31, pp.34-44, 2015.

K. Rodrigues, T. Faria-e-arantes, C. Muccioli, J. Neto, and M. Pinheiro, Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNFblockers, Parasitol Int. 2013, vol.62, issue.3, pp.272-277

S. Lassoued, L. Zabraniecki, F. Marin, and T. Billey, Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum, Feb, vol.36, issue.4, pp.262-265, 2007.

J. Smith, E. Cunningham, and . Jr, Atypical presentations of ocular toxoplasmosis, Current Opinion in Ophthalmology, vol.13, issue.6, pp.387-92, 2002.
DOI : 10.1097/00055735-200212000-00008

O. Durrani, N. Tehrani, J. Marr, P. Moradi, P. Stavrou et al., Degree, duration, and causes of visual loss in uveitis, British Journal of Ophthalmology, vol.88, issue.9, pp.1159-62, 2004.
DOI : 10.1136/bjo.2003.037226

O. Durrani, C. Meads, and P. Murray, Uveitis: a potentially blinding disease. Ophthalmologica, Review, vol.218, issue.4, pp.223-259, 2004.
DOI : 10.1159/000078612

J. Rosenbaum, Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease, Clinical Rheumatology, vol.45, issue.7, pp.999-1002
DOI : 10.1007/s10067-015-2960-8

C. Stolwijk, A. Van-tubergen, J. Castillo-ortiz, and A. Boonen, Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis

B. Bodaghi, B. Wechsler, L. Du-boutin, N. Cassoux, P. Lehoang et al., Chronic Severe Uveitis, Medicine, vol.80, issue.4, 2003.
DOI : 10.1097/00005792-200107000-00005

R. Grajewski, A. Caramoy, K. Frank, A. Rubbert-roth, G. Fätkenheuer et al., Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients, Ocular Immunology and Inflammation, vol.52, issue.4, pp.1-7, 2015.
DOI : 10.1007/s00417-009-1239-7

E. Jakob, M. Reuland, F. Mackensen, N. Harsch, M. Fleckenstein et al., Uveitis subtypes in a german interdisciplinary uveitis center--analysis of 1916 patients, J Rheumatol, vol.36, issue.1, pp.127-163, 2009.

A. Nguyen, P. Sève, L. Scanff, J. Gambrelle, J. Fleury et al., Aspects cliniques et ??tiologiques des uv??ites??: ??tude r??trospective de 121??patients adress??s ?? un centre tertiaire d???ophtalmologie, La Revue de M??decine Interne, vol.32, issue.1, pp.9-16, 2011.
DOI : 10.1016/j.revmed.2010.07.020

E. Bloch-michel and R. Nussenblatt, International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory Disease, American Journal of Ophthalmology, vol.103, issue.2, pp.234-239, 1987.
DOI : 10.1016/S0002-9394(14)74235-7

S. Reeves, F. Sloan, P. Lee, and G. Jaffe, Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort, Ophthalmology. Feb, vol.113, issue.2, p.307, 2006.

A. Bajwa, D. Osmanzada, S. Osmanzada, I. Khan, J. Patrie et al., Epidemiology of uveitis in the mid-Atlantic United States, Clinical Ophthalmology, vol.9, pp.889-901
DOI : 10.2147/OPTH.S80972

N. Acharya, V. Tham, E. Esterberg, D. Borkar, J. Parker et al., Incidence and Prevalence of Uveitis, JAMA Ophthalmology, vol.131, issue.11, pp.1405-1417, 2013.
DOI : 10.1001/jamaophthalmol.2013.4237

D. Gritz and I. Wong, Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study, Ophthalmology, vol.111, issue.3, pp.491-500, 2004.
DOI : 10.1016/j.ophtha.2003.06.014

C. Mccannel, G. Holland, C. Helm, P. Cornell, J. Winston et al., Causes of Uveitis in the General Practice of Ophthalmology, American Journal of Ophthalmology, vol.121, issue.1, pp.35-46, 1996.
DOI : 10.1016/S0002-9394(14)70532-X

P. Zarco, C. González, A. Rodríguez-de-la-serna, E. Peiró, I. Mateo et al., Extra-articular Disease in Patients With Spondyloarthritis. Baseline Characteristics of the Spondyloarthritis Cohort of the AQUILES Study, Reumatolog??a Cl??nica (English Edition), vol.11, issue.2, pp.83-92, 2015.
DOI : 10.1016/j.reumae.2014.11.001

J. Chang, P. Mccluskey, and D. Wakefield, Acute Anterior Uveitis and HLA-B27, Survey of Ophthalmology, vol.50, issue.4, pp.364-88, 2005.
DOI : 10.1016/j.survophthal.2005.04.003

D. Monnet, M. Breban, C. Hudry, M. Dougados, and A. Brézin, Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis*1A study of 175 cases, Ophthalmology, vol.111, issue.4, pp.802-811, 2004.
DOI : 10.1016/j.ophtha.2003.07.011

L. Cabane, S. Baillif, G. Asrarguis, P. Gastaud, V. Queyrel et al., Uv??ite et spondylo-arthrite??: savoir ??voquer une tuberculose??!, Journal Fran??ais d'Ophtalmologie, vol.39, issue.4, pp.83-87
DOI : 10.1016/j.jfo.2015.01.029

A. Gupta, A. Sharma, R. Bansal, and K. Sharma, Classification of Intraocular Tuberculosis, Ocular Immunology and Inflammation, vol.26, issue.1, pp.7-13
DOI : 10.1136/bjo.2010.182659

V. Gupta, S. Shoughy, S. Mahajan, M. Khairallah, J. Rosenbaum et al., Clinics of Ocular Tuberculosis, Ocular Immunology and Inflammation, vol.57, issue.1, pp.14-24, 2015.
DOI : 10.1080/09273940490518702

D. Ponce-de-leon, E. Acevedo-vasquez, S. Alvizuri, C. Gutierrez, M. Cucho et al., Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population, J Rheumatol, vol.35, issue.5, pp.776-81, 2008.

M. Ang, H. Htoon, and S. Chee, Diagnosis of Tuberculous Uveitis: Clinical Application of an Interferon-gamma Release Assay, Ophthalmology, vol.116, issue.7, pp.1391-1397, 2009.
DOI : 10.1016/j.ophtha.2009.02.005

M. Van-der-veen, A. Van-der-heide, A. Kruize, and J. Bijlsma, Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate., Annals of the Rheumatic Diseases, vol.53, issue.4, 1994.
DOI : 10.1136/ard.53.4.224

M. Djebbar, infection risk when receiving anti TNF treatment: crucial and major concern or not so bad reality ?, Rev Mar Rhum, vol.31, pp.34-44, 2015.

K. Rodrigues, T. Faria-e-arantes, C. Muccioli, J. Neto, and M. Pinheiro, Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNFblockers, Parasitol Int. 2013, vol.62, issue.3, pp.272-277

S. Lin, S. Lee, S. Kim, S. Hong, Y. You et al., Prevalence of Toxoplasma gondii and Toxocara canis among patients with uveitis, Ocul Immunol Inflamm, 2014.

S. Lassoued, L. Zabraniecki, F. Marin, and T. Billey, Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum, Feb, vol.36, issue.4, pp.262-265, 2007.
DOI : 10.1016/j.semarthrit.2006.08.004

J. Smith, E. Cunningham, and . Jr, Atypical presentations of ocular toxoplasmosis, Current Opinion in Ophthalmology, vol.13, issue.6, pp.387-92, 2002.
DOI : 10.1097/00055735-200212000-00008

D. Nicholson and E. Wolchok, Ocular Toxoplasmosis in an Adult Receiving Long-Term Corticosteroid Therapy, Archives of Ophthalmology, vol.94, issue.2, pp.248-54, 1976.
DOI : 10.1001/archopht.1976.03910030120009

A. Strangfeld, J. Listing, P. Herzer, A. Liebhaber, K. Rockwitz et al., Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents, JAMA. Feb, vol.18301, issue.7, pp.737-781, 2009.

G. Serac, F. Tubach, M. X. Salmon-céron, D. Ravaud, P. Lioté et al., Risk of Herpes Zoster in Patients Receiving Anti-TNF-?? in the Prospective French RATIO Registry, Journal of Investigative Dermatology, vol.132, issue.3, pp.726-735, 2012.
DOI : 10.1038/jid.2011.383

H. Che, C. Lukas, J. Morel, and B. Combe, Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis, Joint Bone Spine, vol.81, issue.3, pp.215-236, 2014.
DOI : 10.1016/j.jbspin.2013.07.009

J. Franklin, M. Lunt, D. Bunn, D. Symmons, and A. Silman, Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis, Annals of the Rheumatic Diseases, vol.66, issue.3, pp.308-320, 2007.
DOI : 10.1136/ard.2006.057265

P. Emery, G. Gallo, H. Boyd, C. Morgan, C. Currie et al., Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs, Clin Exp Rheumatol, vol.32, issue.5, pp.653-60, 2014.

J. Greenberg, G. Reed, J. Kremer, E. Tindall, A. Kavanaugh et al., Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry, Annals of the Rheumatic Diseases, vol.69, issue.2, pp.380-386, 2010.
DOI : 10.1136/ard.2008.089276

G. Haerter, B. Manfras, Y. De-jong-hesse, H. Wilts, T. Mertens et al., Cytomegalovirus Retinitis in a Patient Treated with Anti--Tumor Necrosis Factor Alpha Antibody Therapy for Rheumatoid Arthritis, Clinical Infectious Diseases, vol.39, issue.9, pp.88-94, 2004.
DOI : 10.1086/425123

B. Segal and M. Sneller, INFECTIOUS COMPLICATIONS OF IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH RHEUMATIC DISEASES, Rheumatic Disease Clinics of North America, vol.23, issue.2, pp.219-256, 1997.
DOI : 10.1016/S0889-857X(05)70327-6

T. Mikuls and L. Moreland, Benefit-Risk Assessment of Infliximab in the Treatment of Rheumatoid Arthritis, Drug Safety, vol.76, issue.9, pp.23-32, 2003.
DOI : 10.2165/00002018-200326010-00003

P. Wiland, A. G?owska, A. Chlebicki, and J. Szechiski, Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis], Pol Arch Med Wewn, vol.108, issue.5, pp.1055-63, 2002.

T. Bongartz, A. Sutton, M. Sweeting, I. Buchan, E. Matteson et al., Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies, JAMA, vol.295, issue.19, p.2482, 2006.
DOI : 10.1001/jama.295.19.2275

S. Engelhard, Z. Haddad, A. Bajwa, J. Patrie, W. Xin et al., Infectious uveitis in Virginia, Clinical Ophthalmology, vol.9, pp.1589-94, 2015.
DOI : 10.2147/OPTH.S86578

W. Lim, R. Powell, and I. Johnston, Tuberculosis and treatment with infliximab, N Engl J Med Feb, vol.21346, issue.8, pp.623-629, 2002.

E. Ruderman, Overview of safety of non-biologic and biologic DMARDs, Rheumatology, vol.51, issue.suppl 6, pp.37-43
DOI : 10.1093/rheumatology/kes283

D. Wendling, A. Joshi, P. Reilly, Y. Jalundhwala, M. Mittal et al., Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database, Current Medical Research and Opinion, vol.30, issue.12, 2014.
DOI : 10.1185/03007995.2014.969368

C. Gaujoux-viala, C. Giampietro, T. Gaujoux, H. Ea, C. Prati et al., Scleritis: a paradoxical effect of etanercept? Etanercept

L. Lim, F. Fraunfelder, and J. Rosenbaum, Do tumor necrosis factor inhibitors cause uveitis? A registry-based study. Arthritis Rheum, pp.3248-52, 2007.
DOI : 10.1002/art.22918

M. Otten, J. Anink, F. Prince, M. Twilt, S. Vastert et al., Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register, Annals of the Rheumatic Diseases, vol.54, issue.(4 Suppl 73), pp.1379-86, 2015.
DOI : 10.1136/annrheumdis-2013-204641

L. Kearsley-fleet, R. Davies, M. Lunt, T. Southwood, and K. Hyrich, Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study, Rheumatology, vol.55, issue.5, pp.2016840-2016847
DOI : 10.1093/rheumatology/kev434

E. Feurer, P. Bielefeld, D. Saadoun, and P. Sève, Biologics in uveitis], Rev Med Interne. 2015 Feb, vol.36, issue.2, pp.107-123

S. Abad, P. Sève, R. Dhote, and A. Brézin, Uv??ites et m??decine interne??: strat??gies diagnostique et th??rapeutique, La Revue de M??decine Interne, vol.30, issue.6, pp.492-500, 2009.
DOI : 10.1016/j.revmed.2008.08.011

A. Desbois, O. Addimanda, A. Bertrand, A. Deroux, L. Pérard et al., Efficacy of Anti-TNF in Severe and Refractory Neuro-Behcet Disease: An Observational Study, Medicine, vol.95, issue.23, pp.2016-3550